Overview

Keystone Industries is a pharmaceutical company headquartered in Gibbstown, United States, founded in 1908, with 201-500 employees.

FDA compliance signals

34 FDA enforcement records linked to this company.

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • recall — Class II2026-06-24

    Defective container:may contain bottles with incomplete seals

  • 4832025-11-07

    Component identity verification

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

  • recall — Class II2024-12-25

    CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

Verified Supplier Partner

Is this Keystone Industries? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.